Multiple business areas in one coherent view.
Each conclusion is paired with evidence confidence, benchmark logic, risk severity, upside potential, and a recommended time horizon-because a naked score creates false precision.
Four steps to the scaling clarity
The exact scope adapts to access, urgency, commissioning party, and report level. The operating principle stays constant: maximum signal, minimum theatre.
Frame the decision
Define the investment question or readiness objective, process stage, known concerns, access constraints, and required output.
Collect evidence
Review available metrics, documents, data-room materials, and targeted management inputs.
Challenge & benchmark
A senior investment and scaleup operator tests the evidence across the 12 dimensions and peer logic.
Deliver the brief
Receive an IC-ready or investor-readiness report, live readout, priority questions, evidence gaps, and-where relevant-a 90-day action plan.
An Action-ready synthesis not a pile of consultant slides.
The report connects findings to decisions. It makes evidence quality, trade-offs, dependencies, and the post-close agenda visible in one structured view.
Proceed to confirmatory diligence-with three conditions.
The company shows real category pull and strong customer advocacy. The principal risks are enterprise concentration, founder-dependent sales, and weak implementation capacity.
Why the thesis can work
| Finding | Severity | Evidence confidence | Investment implication |
|---|---|---|---|
| Revenue concentration Two enterprise accounts influence reported retention quality. | High | 86% | Rebuild account-level cohorts and validate renewal exposure. |
| Founder-dependent sales Founder remains involved in most strategic late-stage deals. | High | 91% | Treat repeatability as a condition, not a future aspiration. |
| International channel economics Partner activation and contribution margin are not yet evidenced. | Medium | 43% | Pause expansion until economics and ownership are validated. |
| Product roadmap capacity Customer commitments may crowd out platform work. | Medium | 61% | Confirm delivery capacity and roadmap trade-offs. |
Stabilise the baseline
- Rebuild account-level retention cohorts
- Define sales qualification and forecast rules
- Recruit implementation leadership
Reduce dependencies
- Separate founder sponsorship from sales ownership
- Install delivery capacity planning
- Create board-level commercial dashboard
Test value creation
- Launch pricing and packaging experiment
- Activate mature-account expansion play
- Re-assess thesis-linked dimensions
Observed strengths
- High strategic pattern recognition
- Strong customer credibility
- Complementarity across product and commercial domains
Scaling dependencies
- Founder remains the default escalation path
- Conflict is delayed until decisions become urgent
- Decision rights are not explicit when founders disagree
Practical actions
- Define founder-only versus delegated decisions
- Introduce a conflict and escalation protocol
- Shift the founder to strategic sponsorship, not process ownership
Illustrative only. A real module requires informed consent, validated instruments, qualified interpretation, and an agreed protocol for sensitive information. It is not a clinical diagnosis or a standalone investment verdict.
Make scaling with a clearer view.
Investors can scope a decision assessment. Founders and CEOs can validate priorities, plans, scalability, and investment readiness before outreach or due diligence.